Literature DB >> 8606090

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.

M W Russell1, Z Moldoveanu, P L White, G J Sibert, J Mestecky, M Michalek S.   

Abstract

Previous attempts to induce mucosal antibodies in rhesus monkeys by enteric immunization have resulted in only modest and short-lived responses, dominated by immunoglobulin M (IgM) antibodies in the plasma. In this study, two groups of rhesus monkeys were immunized intranasally three times at 2-week intervals with a bacterial protein antigen (AgI/II) either chemically coupled to or mixed with the B subunit of cholera toxin (CT), a known potent mucosal immunogen and carrier for other immunogens. Cells secreting antibodies, predominantly of the IgA isotype, to AgI/II and to CT were detected in the peripheral blood 1 week after each immunization, indicating the dissemination of IgA-secreting precursor cells through the mucosal immune system. IgG and, to a lesser extent, IgA antibodies to both proteins were induced in the plasma commencing after the second immunization. Plasma IgE concentrations and IgE antibody levels were not consistently raised during the immunization period. IgA antibodies were found in nasal and vaginal washes. Nasal IgG but not IgA antibodies showed a significant positive correlation with plasma IgG antibody levels, suggesting that they were largely derived by transudation from the circulation. Analysis of the molecular form of vaginal IgA indicated that both secretory and monomeric forms of IgA were present in various proportions. Furthermore, neither IgG nor IgA antibodies in vaginal washes were correlated with plasma antibody responses, suggesting the contribution of locally synthesized antibodies of both isotypes. Comparison of the responses between the two groups of animals showed only sporadic significant differences, indicating that intranasal immunization with AgI/II either coupled to or mixed with the B subunit of CT was equally effective at inducing generalized IgA antibody responses in the mucosal immune system and predominantly IgG antibodies in the plasma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606090      PMCID: PMC173915          DOI: 10.1128/iai.64.4.1272-1283.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein.

Authors:  T Lehner; L A Bergmeier; C Panagiotidi; L Tao; R Brookes; L S Klavinskis; P Walker; J Walker; R G Ward; L Hussain
Journal:  Science       Date:  1992-11-20       Impact factor: 47.728

Review 2.  Immunology and immunopathology of tonsils.

Authors:  P Brandtzaeg; T S Halstensen
Journal:  Adv Otorhinolaryngol       Date:  1992

3.  Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

Review 4.  Cholera toxin and its subunits as potential oral adjuvants.

Authors:  C O Elson
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

5.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Ageing compromises gastrointestinal mucosal immune response in the rhesus monkey.

Authors:  L D Taylor; C K Daniels; D L Schmucker
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

7.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

Review 8.  The role of nasopharyngeal lymphoid tissue.

Authors:  C F Kuper; P J Koornstra; D M Hameleers; J Biewenga; B J Spit; A M Duijvestijn; P J van Breda Vriesman; T Sminia
Journal:  Immunol Today       Date:  1992-06

9.  Genital secretory immune response to chronic simian immunodeficiency virus (SIV) infection: a comparison between intravenously and genitally inoculated rhesus macaques.

Authors:  C J Miller; D W Kang; M Marthas; Z Moldoveanu; H Kiyono; P Marx; J H Eldridge; J Mestecky; J R McGhee
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

10.  Mucosal and systemic antibody formation in the rat after intranasal administration of three different antigens.

Authors:  D M Hameleers; I van der Ven; J Biewenga; T Sminia
Journal:  Immunol Cell Biol       Date:  1991-04       Impact factor: 5.126

View more
  56 in total

1.  Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.

Authors:  E L Johansson; L Wassén; J Holmgren; M Jertborn; A Rudin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Refocusing of B-cell responses following a single amino acid substitution in an antigen.

Authors:  M D Chiesa; P M Martensen; C Simmons; N Porakishvili; J Justesen; G Dougan; I M Roitt; P J Delves; T Lund
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

3.  Generation of female genital tract antibody responses by local or central (common) mucosal immunization.

Authors:  H Y Wu; S Abdu; D Stinson; M W Russell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit.

Authors:  A Rudin; G C Riise; J Holmgren
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Intranasal immunization against dental caries with a Streptococcus mutans-enriched fimbrial preparation.

Authors:  M Fontana; A J Dunipace; G K Stookey; R L Gregory
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 6.  The development and use of vaccine adjuvants.

Authors:  Robert Edelman
Journal:  Mol Biotechnol       Date:  2002-06       Impact factor: 2.695

7.  Immunogenicity of gonococcal transferrin binding proteins during natural infections.

Authors:  Gregory A Price; Marcia M Hobbs; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.

Authors:  N Mielcarek; I Nordström; F D Menozzi; C Locht; J Holmgren
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

9.  Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.

Authors:  Soumi Gupta; Ramesh Janani; Qian Bin; Paul Luciw; Catherine Greer; Silvia Perri; Harold Legg; John Donnelly; Susan Barnett; Derek O'Hagan; John M Polo; Michael Vajdy
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

10.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.